Company intelligence / Profile preview

Correlagen Diagnostics

Waltham, Massachusetts, United States

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Correlagen Diagnostics commercialized comprehensive genetic testing panels, notably for familial cardiac diseases, leveraging next-generation sequencing and automated result interpretation. The CardioGeneScan test covered over 100 cardiac-related genes with high sensitivity. Correlagen was a leading provider in the late 2000s before being acquired; it licensed exclusive diagnostic patents and sublicensed MODY diagnostic rights to Athena Diagnostics.[2][4][6][10]

Therapeutic areas: EndocrinologyCardiovascularPulmonologyRare Diseases
Modalities: Genetic testingNext-generation sequencing
Industry: Molecular Diagnostics

Partnerships

Protedyne (lab automation partnership for GeneXchange platform)

Beyond the preview

Go deeper on Correlagen Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Correlagen Diagnostics.

Explore the full profile